CIK 0000711377
- Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 382367843
- Phone
- +1 517-372-9200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-28 | Rocklin Amy M Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −9,475 | $13.81 | $131K | 18,950 |
| 2024-10-28 | Naemura David H. Chief Financial Officer | Exercise or conversion | +15,504 | $13.81 | $214K | 45,544 |
| 2024-10-28 | Naemura David H. Chief Financial Officer | Shares withheld for taxes | −6,450 | $13.81 | $89K | 39,094 |
| 2024-10-28 | Naemura David H. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −15,504 | $13.81 | $214K | 31,008 |
| 2024-10-28 | Jones Douglas Edward Chief Operating Officer | Exercise or conversion | +15,504 | $13.81 | $214K | 75,671 |
| 2024-10-28 | Jones Douglas Edward Chief Operating Officer | Shares withheld for taxes | −4,512 | $13.81 | $62K | 71,159 |
| 2024-10-28 | Jones Douglas Edward Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −15,504 | $13.81 | $214K | 31,008 |
| 2024-10-28 | ADENT JOHN EDWARD CEO | Exercise or conversion | +38,760 | $13.81 | $535K | 257,409 |
| 2024-10-28 | ADENT JOHN EDWARD CEO | Shares withheld for taxes | −11,280 | $13.81 | $156K | 246,129 |
| 2024-10-28 | ADENT JOHN EDWARD CEO | Exercise or conversion · Restricted Stock Units | −38,760 | $13.81 | $535K | 77,520 |
| 2024-10-24 | Woteki Catherine E Director | Grant or award | +6,075 | $13.58 | $82K | 17,397 |
| 2024-10-24 | Woteki Catherine E Director | Grant or award · Common Stock (Right to Buy) | +18,653 | 18,653 | ||
| 2024-10-24 | Tobin James P Director | Grant or award | +6,075 | $13.58 | $82K | 37,397 |
| 2024-10-24 | Tobin James P Director | Grant or award · Common Stock (Right to Buy) | +18,653 | 18,653 | ||
| 2024-10-24 | RODRIGUEZ RAFAEL A Director | Grant or award | +6,075 | $13.58 | $82K | 17,397 |
| 2024-10-24 | RODRIGUEZ RAFAEL A Director | Grant or award · Common Stock (Right to Buy) | +18,653 | 18,653 | ||
| 2024-10-24 | Green Ronald D Director | Grant or award | +6,075 | $13.58 | $82K | 22,704 |
| 2024-10-24 | Green Ronald D Director | Grant or award · Common Stock (Right to Buy) | +18,653 | 18,653 | ||
| 2024-10-24 | Gupta Aashima Director | Grant or award | +6,075 | $13.58 | $82K | 15,840 |
| 2024-10-24 | Gupta Aashima Director | Grant or award · Common Stock (Right to Buy) | +18,653 | 18,653 |
Page 13 of 21 · 414 trades